The potential role of Marginal Structural Models (MSMs) in testing the effectiveness of antidepressants in the treatment of patients with major depression in everyday clinical practice

References

• Fava M, Rush AJ, Trivedi MH, Nierenberg AA, Thase ME, Sackeim HA, et al. 2003. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study. Psychiatr Clin North Am 26(2):457–494, x.
   Google Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. 2010. Antidepressant drug effects and depression severity: a patient-level meta-analysis. J Am Med Assoc 303(1):47–53.
   PubMed Web of Science ®Google Scholar
• Hegerl U, Mergl R. 2010. The clinical significance of antidepressant treatment effects cannot be derived from placebo-verum response differences. J Psychopharmacol 24(4):445–448.
   Google Scholar
• Hernán MA, Brumback B, Robins JM. 2000. Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men. Epidemiology 11(5):561–570.
   Google Scholar
• Hernán MA, Brumback BA, Robins JM. 2001. Marginal structural models to estimate the joint causal effect of nonrandomized treatments. J Stat Assoc 96(454):440–448.
   Google Scholar
• Hernán MA, Brumback BA, Robins JM. 2002. Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med 21(12):1689–1709.
   Google Scholar
• Hernán MA, Lanoy E, Costagliola D, Robins JM. 2006. Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin Pharmacol Toxicol 98(3):237–242.
   Google Scholar
• Hrobjartsson A, Gotzsche PC. 2001. Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment. New Engl J Med 344(21):1594–1602.
   Google Scholar
• Kaptchuk TJ, Shaw J, Kerr CE, Conboy LA, Kelley JM, Csordas TJ, et al. 2009. “Maybe I made up the whole thing”: placebos and patients’ experiences in a randomized controlled trial. Cult Med Psychiatry 33(3):382–411.
   Google Scholar
• Kennedy SH, Lam RW, Parikh SV, Patten SB, Ravindran AV. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. Introduction. J Affect Disord 117(Suppl 1):S1–2.
   PubMedGoogle Scholar
• Kim SW, Grant JE, Eckert ED, Faris PL, Hartman BK. 2006. Pathological gambling and mood disorders: clinical associations and treatment implications. J Affect Disord 92(1):109–116.
   Google Scholar
• Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. 2008. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5(2):e45.
   PubMed Web of Science ®Google Scholar
• Krogsboll LT, Hrobjartsson A, Gotzsche PC. 2009. Spontaneous improvement in randomised clinical trials: meta-analysis of three-armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol 9:1.
   PubMed Web of Science ®Google Scholar
• Lam RW, Kennedy SH, Grigoriadis S, McIntyre RS, Milev R, Ramasubbu R, et al. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. III. Pharmacotherapy. J Affect Disord 117(Suppl 1):S26–43.
   PubMed Web of Science ®Google Scholar
• Loh A, Simon D, Wills CE, Kriston L, Niebling W, Harter M. 2007. The effects of a shared decision-making intervention in primary care of depression: a cluster-randomized controlled trial. Patient Educ Couns 67(3):324–332.
   Google Scholar
• Moller HJ. 2005. Are placebo-controlled studies required in order to prove efficacy of antidepressants?. World J Biol Psychiatry 6(3):130–131.
   Google Scholar
• Moller HJ. 2008. Isn't the efficacy of antidepressants clinically relevant? A critical comment on the results of the metaanalysis by Kirsch et al. 2008. Eur Arch Psychiatry Clin Neurosci 258(8):451–455.
   Google Scholar
• Moller HJ. 2009. Antidepressants: controversies about their efficacy in depression, their effect on suicidality and their place in a complex psychiatric treatment approach. World J Biol Psychiatry 10(3):180–195.
   Google Scholar
• Moller HJ, Maier W. 2010. Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations. Eur Arch Psychiatry Clin Neurosci 260(1):25–39.
   Google Scholar
• Moodie EEM, Delaney JAC, Levebre G, Platt RW. 2008. Missing confounding data in marginal structural models: a comparison of inverse probability weighting and multiple imputation. Int J Biostat 4(1). Article 13. http://www.bepress.com/ijb/vol4/iss1/13.
   Google Scholar
• Mortimer KM, Neugebauer R, van der Laan M, Tager IB. 2005. An application of model-fitting procedures for marginal structural models. Am J Epidemiol 162(4):382–388.
   Google Scholar
• Muller-Oerlinghausen B. 1994. Multidimensional assessment of acute and long-term effects in antidepressant drug trials. Pharmacopsychiatry 27(Suppl 1):18–20.
   Google Scholar
• Murphy SA, van der Laan MJ, Robins JM. 2001. Marginal mean models for dynamic regimes. J Am Stat Assoc 96(456):1410–1423.
   Google Scholar
• Nutt DJ, Davidson JR, Gelenberg AJ, Higuchi T, Kanba S, Karamustafalioglu O, et al. 2010. International consensus statement on major depressive disorder. J Clin Psychiatry 71(Suppl E1):e08.
   Google Scholar
• Otto MW, Nierenberg AA. 2002. Assay sensitivity, failed clinical trials, and the conduct of science. Psychother Psychosom 71(5):241–243.
   Google Scholar
• Parikh SV, Segal ZV, Grigoriadis S, Ravindran AV, Kennedy SH, Lam RW, Patten SB. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord 117(Suppl 1):S15–25.
   Google Scholar
• Parker G, Anderson IM, Haddad P. 2003. Clinical trials of antidepressant medications are producing meaningless results. Br J Psychiatry 183:102–104.
   PubMed Web of Science ®Google Scholar
• Patten SB, Kennedy SH, Lam RW, O'Donovan C, Filteau MJ, Parikh SV, Ravindran AV. 2009. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. I. Classification, burden and principles of management. J Affect Disord 117(Suppl 1):S5–14.
   PubMed Web of Science ®Google Scholar
• Posternak MA, Miller I. 2001. Untreated short-term course of major depression: a meta-analysis of outcomes from studies using wait-list control groups. J Affect Disord 66(2–3):139–146.
   Google Scholar
• Quitkin FM, Rabkin JG, Gerald J, Davis JM, Klein DF. 2000. Validity of clinical trials of antidepressants. Am J Psychiatry 157(3):327–337.
   Google Scholar
• Riedel M, Strassnig M, Muller N, Zwack P, Moller HJ. 2005. How representative of everyday clinical populations are schizophrenia patients enrolled in clinical trials?. Eur Arch Psychiatry Clin Neurosci 255(2):143–148.
   Google Scholar
• Rihmer Z, Gonda X. 2008. Is drug-placebo difference in short-term antidepressant drug trials on unipolar major depression much greater than previously believed?. J Affect Disord 108(3):195–198.
   Google Scholar
• Robins JM, Greenland S, Hu F. 1999. Estimation of the causal effect of a time-varying exposure on the marginal mean of a repeated binary outcome. J Am Stat Assoc 94(447):687–700.
   Google Scholar
• Robins JM, Hernán MA, Brumback B. 2000. Marginal structural models and causal inference in epidemiology. Epidemiology 11(5):550–560.
   PubMed Web of Science ®Google Scholar
• Rutherford BR, Sneed JR, Roose SP. 2009. Does study design influence outcome?. The effects of placebo control and treatment duration in antidepressant trials. Psychother Psychosom 78(3):172–181.
   Google Scholar
• Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. 1996. Evidence based medicine: what it is and what it isn't. BMJ 312(7023):71 72.
   Google Scholar
• Seemuller F, Moller HJ, Obermeier M, Adli M, Bauer M, Kronmuller K, et al. 2010. Do efficacy and effectiveness samples differ in antidepressant treatment outcome? An analysis of eligibility criteria in randomized controlled trials. J Clin Psychiatry 71(11):1425–1433.
   Google Scholar
• Sinyor M, Levitt AJ, Cheung AH, Schaffer A, Kiss A, Dowlati Y, Lanctot KL. 2010. Does inclusion of a placebo arm influence response to active antidepressant treatment in randomized controlled trials? Results from pooled and meta-analyses. J Clin Psychiatry 71(3):270–279.
   Google Scholar
• Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. 2008. Selective publication of antidepressant trials and its influence on apparent efficacy. New Engl J Med 358(3): 252–260.
   PubMed Web of Science ®Google Scholar
• Turner EH, Rosenthal R. 2008. Efficacy of antidepressants. Br Med J 336(7643):516–517.
   Google Scholar
• Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, et al. 2009. Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. Am J Psychiatry 166(5):599–607.
   PubMed Web of Science ®Google Scholar